- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT03626792
Effect of Mat Pilates Training on Women After Menopause
7. mars 2022 oppdatert av: Jaqueline Pontes Batista, Federal University of Uberlandia
Effect of Mat Pilates Training on Climacteric Symptoms and Physiological Changes in Women After Menopause
This project aims to verify the chronic effect of Mat Pilates exercise on climacteric symptoms, ambulatory blood pressure responses, lipid and glucose profile and pro and anti-inflammatory and antioxidant markers in postmenopausal normotensive and hypertensive women.
All volunteers received the same intervention.
Studieoversikt
Status
Fullført
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
The Pilates program was performed three times a week for 12 weeks.
Initially a familiarization was made regarding the principles of the method.
All volunteers underwent 24-hour blood pressure assessment using ambulatory blood pressure measurement (ABPM) and venous blood samples were collected from fasting, saliva and questionnaires before and after the Pilates training period.
Studietype
Intervensjonell
Registrering (Faktiske)
50
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiesteder
-
-
Minas Gerais
-
Uberlândia, Minas Gerais, Brasil, 38400-678
- Jaqueline Pontes Batista
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
40 år til 70 år (Voksen, Eldre voksen)
Tar imot friske frivillige
Ja
Kjønn som er kvalifisert for studier
Hunn
Beskrivelse
Inclusion Criteria:
- Women between the ages of 40 and 70;
- Be post menopausal (amenorrhea for at least 12 months);
- Medical release to perform physical activities.
- Do not present physical problems or cardiovascular complications that prevent the performance of physical exercises;
Exclusion Criteria:
- To present a history of stroke or acute myocardial infarction;
- Smoking;
- Diagnosis of Diabetes Mellitus.
- Present renal pathologies.
- Use medications that interfere with lipid metabolism;
- Use of antihypertensive drugs (except for the hypertensive group);
- Use hormone replacement therapies;
- Present gastrointestinal conditions.
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Ikke-randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Annen: Hypertensive group
The Mat Pilates session was held lasting 50 minutes of exercises with the first 5 minutes heating and in each exercise performing 10 repetitions with 45 seconds of rest between one exercise and another.
For practice, are used only mats, and alternative devices such as the Swiss ball and the flexible ring, as well as body weight and the force of gravity as resistance factors and Borg's subjective perception of effort scale for intensity parameters.
The 20 exercises were chosen through the classic exercises thus classified by the creator of the Joseph Pilates method.During the sessions, volunteers were instructed on correct breathing without performing the valsalva maneuver.
|
Pilates 12-week training on the ground, often 3 times a week for 50 minutes of prescribed method exercises.
|
|
Annen: Normotensive group
The Mat Pilates session was held lasting 50 minutes of exercises with the first 5 minutes heating and in each exercise performing 10 repetitions with 45 seconds of rest between one exercise and another.
For practice, are used only mats, and alternative devices such as the Swiss ball and the flexible ring, as well as body weight and the force of gravity as resistance factors and Borg's subjective perception of effort scale for intensity parameters.
The 20 exercises were chosen through the classic exercises thus classified by the creator of the Joseph Pilates method.During the sessions, volunteers were instructed on correct breathing without performing the valsalva maneuver.
|
Pilates 12-week training on the ground, often 3 times a week for 50 minutes of prescribed method exercises.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Blood pressure
Tidsramme: Change from Baseline at 12 weeks
|
Resting diastolic and systolic blood pressures will be monitored by Microlife® BP 3BT0A automatic monitor in mmHg.
|
Change from Baseline at 12 weeks
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Ambulatory blood pressure monitoring
Tidsramme: Change from Baseline at 12 weeks
|
Ambulatory blood pressure monitoring will be monitored during 24 hours using a Dyna+ ABPM device in mmHg.
|
Change from Baseline at 12 weeks
|
|
Kupperman - Blatt Index
Tidsramme: Change from Baseline at 12 weeks
|
The climacteric symptoms will be evaluated by the following questionnaire Kupperman - Blatt Index.
The questionnaire has scores that from 0 to 19 indicate mild symptoms, 20 to 35 moderate and greater than 35 symptoms of severe climacteric.
|
Change from Baseline at 12 weeks
|
|
Cervical Scale
Tidsramme: Change from Baseline at 12 weeks
|
The climacteric symptoms will be evaluated by the following questionnaire Cervical Scale.
The questionnaire does not have scales.
Indicates only a high or low score regarding the presence of climacteric symptoms.
|
Change from Baseline at 12 weeks
|
|
Menopause Rating Scale (MRS)
Tidsramme: Change from Baseline at 12 weeks
|
The climacteric symptoms will be evaluated by the following questionnaire Menopause Rating Scale (MRS).
The scores from 0 to 4 of the questionnaire indicate absence of symptoms, as well as from 5 to 8 presence of mild symptoms, 9 to 15 moderate and greater than 16 symptoms of severe climacteric.
|
Change from Baseline at 12 weeks
|
|
Sleep quality
Tidsramme: Change from Baseline at 12 weeks
|
Sleep quality will be assessed by the Pittsburgh Sleep Quality Index (PSQI).A score of 0 to 4 indicates a good quality of sleep, 5 to 10 quality of bad sleep and greater than 10 the presence of sleep disorder.
|
Change from Baseline at 12 weeks
|
Andre resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Biochemical analyzes
Tidsramme: Change from Baseline at 12 weeks
|
From the serum and/or plasma and saliva samples collected and stored, analyzes for lipid profile (total cholesterol and fractions, and triglycerides) and glycemia at rest and for the concentrations of inflammatory cytokines and changes in the activity of the Antioxidant system.
|
Change from Baseline at 12 weeks
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Etterforskere
- Studieleder: Guilherme M Puga, Phd, Federal University of Uberlândia
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Faktiske)
5. august 2017
Primær fullføring (Faktiske)
20. desember 2017
Studiet fullført (Faktiske)
28. mars 2018
Datoer for studieregistrering
Først innsendt
24. april 2017
Først innsendt som oppfylte QC-kriteriene
9. august 2018
Først lagt ut (Faktiske)
13. august 2018
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
22. mars 2022
Siste oppdatering sendt inn som oppfylte QC-kriteriene
7. mars 2022
Sist bekreftet
1. mars 2022
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Andre studie-ID-numre
- 68408116.9.0000.5152
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .